Skip to main content
Loading ResearchHub…
Cited by — Cost-effectiveness of pembrolizumab plus chemoradiotherapy versus placebo plus chemoradiotherapy for high-risk locally advanced cervical cancer in Saudi Arabia | ResearchHub - ResearchHub